Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Donna L. Kerney, Diana Paradis & Stephen Brunton. (2007) Patient perceptions of insulin detemir as reported through patient telephone surveys. Current Medical Research and Opinion 23:9, pages 2043-2049.
Read now
Read now
Stephen C Bain & Ali D Kamal. (2006) Safety and side effects of the insulin analogues. Expert Opinion on Drug Safety 5:3, pages 349-350.
Read now
Read now
Claudio D González & Guillermo Di Girolamo. (2006) Safety and side effects of the insulin analogues. Expert Opinion on Drug Safety 5:2, pages 195-196.
Read now
Read now
Articles from other publishers (13)
Mohamed Mahameed, Shuai Xue, Bozhidar‐Adrian Stefanov, Ghislaine Charpin‐El Hamri & Martin Fussenegger. (2022) Engineering a Rapid Insulin Release System Controlled By Oral Drug Administration. Advanced Science 9:9, pages 2105619.
Crossref
Crossref
Qi Qin, Yan Chen, Yongbo Li, Jing Wei, Xiaoting Zhou, Fuyin Le, Hong Hu & Tingtao Chen. (2021) Intestinal Microbiota Play an Important Role in the Treatment of Type I Diabetes in Mice With BefA Protein. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Shanshan Qi, Jia He, Hongxing Zheng, Chen Chen & Shiqiang Lan. (2019) Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover. Molecules 24:10, pages 1871.
Crossref
Crossref
Shiqi Dong, Yuan Gu, Guangli Wei, Duanyun Si & Changxiao Liu. (2018) Determination of liraglutide in rat plasma by a selective liquid chromatography-tandem mass spectrometry method: Application to a pharmacokinetics study. Journal of Chromatography B 1091, pages 29-35.
Crossref
Crossref
Sharon T. Cameron, Anna Glasier & Anne Johnstone. (2012) Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception. Contraception 85:5, pages 458-464.
Crossref
Crossref
I. Brock Jacobsen, B. F. Vind, L. Korsholm, A. Flyvbjerg, J. Frystyk, J. J. Holst, H. Beck-Nielsen & J. E. Henriksen. (2011) Counter-regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double-blinded randomized cross-over study. Acta Physiologica 202:3, pages 337-347.
Crossref
Crossref
Lizette Gil-del Valle, Lazara de la C. Milian, Arturo Toledo, Jenny Avila, Rolando Tápanes, Isis Llera, María A. Otero & Gregorio Martínez-Sánchez. (2011) Modification in redox status of diabetes mellitus type 1 patients after insulin transition. Biomedicine & Preventive Nutrition 1:1, pages 12-18.
Crossref
Crossref
Lizette Gil-del Valle, Lazara de la C. Milian, Arturo Toledo, Jenny Avila, Rolando Tápanes, Isis Llera, María A. Otero & Gregorio Martínez-Sánchez. (2010) WITHDRAWN: Modification in redox status of diabetes mellitus type 1 patients after insulin transition. Biomedicine & Pharmacotherapy.
Crossref
Crossref
Mark Peyrot, Richard R. Rubin & Kamlesh Khunti. (2010) Addressing barriers to initiation of insulin in patients with type 2 diabetes. Primary Care Diabetes 4, pages S11-S18.
Crossref
Crossref
Iben Brock Jacobsen, J.E. Henriksen, O. Hother-Nielsen, W. Vach & H. Beck-Nielsen. (2009) Evidence-based insulin treatment in type 1 diabetes mellitus. Diabetes Research and Clinical Practice 86:1, pages 1-10.
Crossref
Crossref
Patrick J. Boyle & John Zrebiec. (2008) Impact of therapeutic advances on hypoglycaemia in type 2 diabetes. Diabetes/Metabolism Research and Reviews 24:4, pages 257-285.
Crossref
Crossref
Luigi Meneghini. (2007) Why and How to Use Insulin Therapy Earlier in the Management of Type 2 Diabetes. Southern Medical Journal 100:2, pages 164-174.
Crossref
Crossref
Javier Morales. (2007) Defining the Role of Insulin Detemir in Basal Insulin Therapy. Drugs 67:17, pages 2557-2584.
Crossref
Crossref